1-4 of 4
Arati Raziuddin
Close
Sort by
Journal Articles

The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP

Thomas J. Sayers, Alan D. Brooks, Crystal Y. Koh, Weihong Ma, Naoko Seki, Arati Raziuddin, Bruce R. Blazar, Xia Zhang, Peter J. Elliott, William J. Murphy
Journal: Blood
Blood (2003) 102 (1): 303–310.
https://doi.org/10.1182/blood-2002-09-2975
Published: 2003
Journal Articles

Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens

Arati Raziuddin, Dan L. Longo, Michael Bennett, Robin Winkler-Pickett, John R. Ortaldo, William J. Murphy
Journal: Blood
Blood (2002) 100 (8): 3026–3033.
https://doi.org/10.1182/blood.V100.8.3026
Published: 2002
Journal Articles

Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo

Crystal Y. Koh, Bruce R. Blazar, Thaddeus George, Lisbeth A. Welniak, Christian M. Capitini, Arati Raziuddin, William J. Murphy, Michael Bennett
Journal: Blood
Blood (2001) 97 (10): 3132–3137.
https://doi.org/10.1182/blood.V97.10.3132
Published: 2001
Journal Articles

Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2 b bone marrow cell allografts

Arati Raziuddin, Michael Bennett, Robin Winkler-Pickett, John R. Ortaldo, Dan L. Longo, William J. Murphy
Journal: Blood
Blood (2000) 95 (12): 3840–3844.
https://doi.org/10.1182/blood.V95.12.3840
Published: 2000